Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network
- PMID: 29374196
- PMCID: PMC5786038
- DOI: 10.1038/s41598-018-19907-9
Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network
Abstract
Ultraviolet radiation (UVR) exposure and family history are major associated risk factors for the development of non-melanoma skin cancer (NMSC). The objective of this study was to develop and validate a multi-parameterized artificial neural network based on available personal health information for early detection of NMSC with high sensitivity and specificity, even in the absence of known UVR exposure and family history. The 1997-2015 NHIS adult survey data used to train and validate our neural network (NN) comprised of 2,056 NMSC and 460,574 non-cancer cases. We extracted 13 parameters for our NN: gender, age, BMI, diabetic status, smoking status, emphysema, asthma, race, Hispanic ethnicity, hypertension, heart diseases, vigorous exercise habits, and history of stroke. This study yielded an area under the ROC curve of 0.81 and 0.81 for training and validation, respectively. Our results (training sensitivity 88.5% and specificity 62.2%, validation sensitivity 86.2% and specificity 62.7%) were comparable to a previous study of basal and squamous cell carcinoma prediction that also included UVR exposure and family history information. These results indicate that our NN is robust enough to make predictions, suggesting that we have identified novel associations and potential predictive parameters of NMSC.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
A multi-parameterized artificial neural network for lung cancer risk prediction.PLoS One. 2018 Oct 24;13(10):e0205264. doi: 10.1371/journal.pone.0205264. eCollection 2018. PLoS One. 2018. PMID: 30356283 Free PMC article.
-
Development and Validation of a Multiparameterized Artificial Neural Network for Prostate Cancer Risk Prediction and Stratification.JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.17.00119. JCO Clin Cancer Inform. 2018. PMID: 30652591 Free PMC article.
-
Development and validation of a neural network for NAFLD diagnosis.Sci Rep. 2021 Oct 12;11(1):20240. doi: 10.1038/s41598-021-99400-y. Sci Rep. 2021. PMID: 34642390 Free PMC article.
-
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3. Adv Exp Med Biol. 2017. PMID: 29124688 Review.
-
Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships.JAMA Dermatol. 2014 Oct;150(10):1063-71. doi: 10.1001/jamadermatol.2014.762. JAMA Dermatol. 2014. PMID: 25103031 Review.
Cited by
-
Artificial intelligence and skin cancer.Front Med (Lausanne). 2024 Mar 19;11:1331895. doi: 10.3389/fmed.2024.1331895. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38566925 Free PMC article. Review.
-
The leading global health challenges in the artificial intelligence era.Front Public Health. 2023 Nov 27;11:1328918. doi: 10.3389/fpubh.2023.1328918. eCollection 2023. Front Public Health. 2023. PMID: 38089037 Free PMC article. Review.
-
Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach.J Multidiscip Healthc. 2023 Jun 26;16:1779-1791. doi: 10.2147/JMDH.S410301. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 37398894 Free PMC article. Review.
-
AI-Powered Diagnosis of Skin Cancer: A Contemporary Review, Open Challenges and Future Research Directions.Cancers (Basel). 2023 Feb 13;15(4):1183. doi: 10.3390/cancers15041183. Cancers (Basel). 2023. PMID: 36831525 Free PMC article. Review.
-
Statistical biopsy: An emerging screening approach for early detection of cancers.Front Artif Intell. 2023 Jan 20;5:1059093. doi: 10.3389/frai.2022.1059093. eCollection 2022. Front Artif Intell. 2023. PMID: 36744110 Free PMC article.
References
-
- American Cancer Society. Key statistics for basal and squamous cell skin cancers, https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/about/.... Accessed July 14th (2017).
-
- Rogers, H. W., Weinstock, M. A., Feldman, S. R. & Coldiron, B. M. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the us population, 2012. JAMA Dermatol.151(10), 1081–1086, 10.1001/jamadermatol.2015.1187 (2015) - PubMed
-
- Rogers HW, et al. Incidence estimate of nonmelanoma skin cancer in the united states, 2006. Arch Dermatol. 2010 Mar. 2010;146(3):283–7. - PubMed
-
- Eisemann, N. et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence, 134(1), 43–50, 10.1038/jid.2013.304 (2014). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical